Journal of Medicinal Chemistry · 2008 · 136 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryPharmacophore ModelingChemical Library DesignEnzyme InhibitionMolecular DockingMulti-target Drug DesignPharmacophore ScreeningPharmacophore-based Lead DiscoveryCombinatorial Library DesignCommon Pharmacophore MappingDocking-based Drug DesignDual-target InhibitorsLeukotriene A4 SynthaseMultitarget Drug DesignPharmacophore Model ConstructionPhospholipase A2 Inhibition
Multitarget drugs have been to be found effective in controlling complex diseases. However, how to design multitarget drugs presents a great challenge. We have developed a computer-assisted strategy to screen for multitarget inhibitors using a combination of molecular docking and common pharmacophore matching. This strategy was successfully applied to screen for dual-target inhibitors against both the human leukotriene A(4) hydrolase (LTA4H-h) and the human nonpancreatic secretory phospholipase A2 (hnps-PLA2). Three compounds screened from the chemical database MDL Available Chemical Directory were found to inhibit these two enzymes at the 10 microM level. Moreover, one synthetic compound matching the common pharmacophores inhibits LTA4H-h and hnps-PLA2 with IC(50) values of 35 nM and 7.3 microM, respectively. The common pharmacophore model can also be used to search small molecule databases or collections of existing inhibitors, as well as to guide combinatorial library design to search for ideal multitarget inhibitors.
21
Robustness against mutations in genetic networks of yeast
Andreas Wagner · Nature Genetics · 2000 · 423 citations
Life Sciences, Biology, Genetics +10